Gilead will pay $5.1 billion to boost its stake in Galapagos and gain rights outside Europe to the Belgian biotech company’s treatments in development
Gilead Sciences Inc. will pay $5.1 billion to boost its stake in Galapagos NV and gain rights outside Europe to the Belgian biotechnology company’s treatments in development, in a broad research collaboration aimed at increasing growth at the drugmakers.
Under the terms of the deal, to be announced Sunday, Gilead will make a $3.95 billion payment to Galapagos. It also will invest $1.1 billion, or €140.59 a share, to increase its stake in the drugmaker to 22% from 12.3%. That represents a 20% premium to the 30-day...
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
IMF to ship $5.4 billion to Argentina under standby loan dealThe International Monetary Fund board said on Friday it would ship $5.4 billion ...
Leer más »
Football: Belgian champions Genk sign son of HagiBelgian champions Racing Genk have strengthened their squad for the new season w...
Leer más »
How the Creators of Restaurant Drama ‘Sweetbitter’ Raised the Stakes For Season 2Stephanie Danler and Stu Zicherman talk about expanding the world of their restaurant drama in its second season
Leer más »
Why much is at stake in a tale of teachers in Middle AmericaA new sensitivity over discrimination in the secular world is making it harder for religious institutions to apply a don’t-ask-don’t-tell policy
Leer más »